Please note that masks are still required in all Blue Ridge Cancer Care offices regardless of vaccination status.
Learn more about this and other current Covid-19 policies.

About Us

NCI News

A high-fiber diet may improve the response of melanoma patients to immunotherapy
12/23/2021

NCI researchers have found that a diet rich in fiber may help some people being treated for melanoma respond to immunotherapy treatment by influencing the gut microbiome. The new findings come from an analysis of people with melanoma and mouse models of the disease.


Drug combination helps children with acute promyelocytic leukemia avoid conventional chemotherapy
11/11/2021

A Children’s Oncology Group trial shows that the combination of all-trans retinoic acid and arsenic trioxide is highly effective in children with acute promyelocytic leukemia. The therapy avoids or minimizes the use of conventional chemotherapy.


Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
11/04/2021

NCI researchers have found that adding the targeted therapy ibrutinib (Imbruvica) to standard chemotherapy can improve how long some younger people with a specific form of diffuse large B-cell lymphoma live. The new findings come from a new analysis of a previously conducted phase 3 clinical trial called Phoenix.


Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
11/04/2021

NCI researchers have found that adding the targeted therapy ibrutinib (Imbruvica) to standard chemotherapy can improve how long some younger people with a specific form of diffuse large B-cell lymphoma live. The new findings come from a new analysis of a previously conducted phase 3 clinical trial called Phoenix.


Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019
10/26/2021

Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.


Annual Report to the Nation Part 2: Patient economic burden of cancer care more than $21 billion in the United States in 2019
10/26/2021

Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.


NCI study highlights pandemic’s disproportionate impact on Black, American Indian/Alaska Native, and Latino adults
10/04/2021

A large surveillance study led by NCI researchers suggests that the global COVID-19 pandemic has caused more deaths in the United States among Black, American Indian/Alaska Native, and Latino individuals than among white or Asian individuals.


NCI study highlights pandemic’s disproportionate impact on Black, American Indian/Alaska Native, and Latino adults
10/04/2021

A large surveillance study led by NCI researchers suggests that the global COVID-19 pandemic has caused more deaths in the United States among Black, American Indian/Alaska Native, and Latino individuals than among white or Asian individuals.


NIH study illuminates origins of lung cancer in never smokers
9/06/2021

NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer these individuals.


NIH study illuminates origins of lung cancer in never smokers
9/06/2021

NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer these individuals.